ribavirin has been researched along with Bone Marrow Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boumis, E; Capone, A; Drapeau, CM; Noto, P; Petrosillo, N; Remotti, D | 1 |
| Bayne, JH; Grever, MR; Hanauske, AR; Jayaram, HN; Melink, TJ; Phillips, JL; Sarosy, G; Von Hoff, DD | 1 |
2 other study(ies) available for ribavirin and Bone Marrow Diseases
| Article | Year |
|---|---|
Bone marrow toxicity in HCV genotype 5a-infected patient after peg-IFN alpha-2a and ribavirin therapy.
Topics: Antiviral Agents; Bone Marrow; Bone Marrow Diseases; Fibrosis; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Pancytopenia; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2008 |
Phase I trial and biochemical evaluation of tiazofurin administered on a weekly schedule.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Bone Marrow Diseases; Drug Evaluation; Female; Humans; Male; Middle Aged; Ribavirin; Ribonucleosides | 1990 |